Surgical analysis of pulmonary aspergilloma.
- Author:
Chong Kook LEE
1
;
Seung Il PARK
;
Jae Jung SEO
;
Jun Ho WON
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.
- Publication Type:Original Article
- Keywords:
Aspergillosis, lung;
Lung surgery
- MeSH:
Hemoptysis;
Hemorrhage;
Humans;
Lung;
Lung Diseases;
Mastectomy, Segmental;
Mortality;
Pneumonectomy;
Preexisting Condition Coverage;
Pulmonary Aspergillosis;
Thoracoplasty;
Tuberculosis, Pulmonary;
Wound Infection
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2000;33(3):245-251
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Pulmonary aspergilloma is a potential life-threatening disease resulting from massive hemoptysis. Pulmonary aspergilloma has been treated surgically for many years, however, it has also had higher risk of mortality and complication rate. The purpose of this study is to analyze the operative methods and the types of complications. MATERIAL AND METHOD: Sixty patients who underwent surgical resection for pulmonary their medical reconrds. RESULT: The mean age was 46.3+/-13.4 years(range 20 to 76 years). The most common clinical presentation was hemoptysis which occurred in 48 patients(80%). Pulmonary tuberculosis was the most common pre-existing disease, occurri9ng in 28 patients(46.7%). The other associated lung diseases were bronchiectasis(n=11), silicosis(n=2), and chronic pnumonia(n=1). Operative proceudres wer lobectomy in 35 patients, pneumonectomy in 6, segmentectomy in 5, lobectomy and thoracoplasty in 3, segmentectomy and thoracopasty in 1, and cavernostomy in 10. The operative mortality was 6%(n=3) in lung resection patients but 0% in cavernostomy patients. The most common complications were prolonged air leakage, wound infection and postoperative bleeding. CONCLUSIONS: In most cases of pulmonary aspergilloma surgical resectin remains the only effective therapy. However, cavernostomy may be more effective for pulmonary aspergilloma patients with decreased pulmonary functions and for patients with high risk for lung resection.
